Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GNMSF) EBITDA Margin (2024 - 2025)

Historic EBITDA Margin for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to 90.17%.

  • Genmab A's EBITDA Margin fell 1237600.0% to 90.17% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year decrease of 319400.0%. This contributed to the annual value of 0.0% for FY2025, which is 311400.0% down from last year.
  • Per Genmab A's latest filing, its EBITDA Margin stood at 90.17% for Q4 2025, which was down 1237600.0% from 39.82% recorded in Q3 2025.
  • Genmab A's EBITDA Margin's 5-year high stood at 39.82% during Q3 2025, with a 5-year trough of 90.17% in Q4 2025.